Allison C Rosenthal (Allison Rosenthal)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

American journal of hematology

Current treatment options in oncology

Leukemia & lymphoma

Current oncology reports

Mayo Clinic Hospital

Utah State University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Hospital Jan 01 2016

United States

Consultant :: Hematology Medical Oncology

Education History

Utah State University Jul 01 1999 - Jun 30 2004

United States

BSC

Publications

Aung Myint Tun, Romil D Patel, Frederique St-Pierre, Evguenia Ouchveridze, Alex Niu, Thorunn Thordardottir, Jennifer Obasi, Allison C Rosenthal, Priyanka A Pophali, Timothy S Fenske, Reem Karmali, Sairah Ahmed, Patrick B Johnston
Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study. American journal of hematology 99 (9) (2024)
Aung Myint Tun, Romil D Patel, Frederique St-Pierre, Evguenia Ouchveridze, Alex Niu, Thorunn Thordardottir, Jennifer Obasi, Allison C Rosenthal, Priyanka A Pophali, Timothy S Fenske, Reem Karmali, Sairah Ahmed, Patrick B Johnston
Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study. American journal of hematology (2024)
Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqbal, Wei He, Albert S Kearney, Timothy P McKinlay, Min Gui, Anthony R Mato
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: an open-label, multicenter, phase 1a/1b study. American journal of hematology (2023)
Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqbal, Wei He, Albert S Kearney, Timothy P McKinlay, Min Gui, Anthony R Mato
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study. American journal of hematology (2023)
Allison C Rosenthal, Adam S DuVall, Justine M Kahn, Niloufer Khan
Disparities in care and outcomes for adolescent and young adult lymphoma patients. EJHaem 4 (4) (2023)
Omran Saifi, Scott C Lester, William G Breen, William G Rule, Yi Lin, N Nora Bennani, Allison C Rosenthal, Javier Munoz, Hemant S Murthy, Mohamed A Kharfan-Dabaja, Jennifer L Peterson, Bradford S Hoppe
Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. American journal of hematology (2023)
Allison C Rosenthal
Quality of Life and Survivorship in Lymphoma. Current oncology reports 24 (9) (2022)
Anagha Deshpande, William Rule, Allison C Rosenthal
Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas. Current treatment options in oncology 23 (1) (2022)
Caitlin M Brumfiel, Meera H Patel, David J DiCaudo, Allison C Rosenthal, Mark R Pittelkow, Aaron R Mangold
Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination. Leukemia & lymphoma 62 (10) (2021)
Emily Galloway, Melody Griffith, Allison C Rosenthal
Multidisciplinary Management of Adolescent and Young Adult Patients with Hodgkin Lymphoma. Current treatment options in oncology 22 (7) (2021)
Jithma A Abeykoon, Saurabh Zanwar, Stephen M Ansell, Eli Muchtar, Rong He, Patricia T Greipp, Rebecca L King, Sikandar Ailawadhi, Jonas Paludo, Jeremy T Larsen, Thomas M Habermann, David J Inwards, Ronald S Go, Gita Thanarajasingam, Francis Buadi, Angela Dispenzieri, Carrie A Thompson, Thomas E Witzig, Martha Lacy, Wilson I Gonsalves, Grzegorz S Nowakowski, David Dingli, Sundararajan Vincent Rajkumar, Robert A Kyle, Taimur Sher, Vivek Roy, Allison C Rosenthal, Asher A Chanan-Khan, Craig Reeder, Morie A Gertz, Shaji K Kumar, Prashant Kapoor
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia. American journal of hematology 96 (8) (2021)
Talal Hilal, Zhen Wang, Diana Almader-Douglas, Allison C Rosenthal, Craig B Reeder, Tania Jain
Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysis. American journal of hematology 93 (10) (2018)
Priyanka A Pophali, Andrew Ip, Melissa C Larson, Allison C Rosenthal, Matthew J Maurer, Christopher R Flowers, Brian K Link, Umar Farooq, Andrew L Feldman, Cristine Allmer, Susan L Slager, Thomas E Witzig, Thomas M Habermann, Jonathon B Cohen, James R Cerhan, Carrie A Thompson
The association of physical activity before and after lymphoma diagnosis with survival outcomes. American journal of hematology 93 (12) (2018)
Allison C Rosenthal, Amylou C Dueck, Stephen Ansell, Katherine Gano, Christopher Conley, Grzegorz S Nowakowski, John Camoriano, Jose F Leis, Joseph R Mikhael, A Keith Stewart, David Inwards, David Dingli, Shaji Kumar, Pierre Noel, Morie Gertz, Luis Porrata, Stephen Russell, Joseph Colgan, Rafael Fonseca, Thomas M Habermann, Prashant Kapoor, Francis Buadi, Nelson Leung, Rodger Tiedemann, Thomas E Witzig, Craig Reeder
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy. American journal of hematology 92 (5) (2017)

Allison C Rosenthal.css-eqlu8i{font-size:small;padding-left:4px;} (Allison Rosenthal)

Publication Activity (10 Years)

Top Topics

Top Venues

Allison C Rosenthal (Allison Rosenthal)